Cargando…
Clinical and Immunological Factors That Distinguish COVID-19 From Pandemic Influenza A(H1N1)
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19), is a global health threat with the potential to cause severe disease manifestations in the lungs. Although COVID-19 has been extensively characterized clinically, the factors...
Ejemplares similares
-
CXCL17 Is a Specific Diagnostic Biomarker for Severe Pandemic Influenza A(H1N1) That Predicts Poor Clinical Outcome
por: Choreño-Parra, Jose Alberto, et al.
Publicado: (2021) -
Corrigendum: CXCL17 Is a Specific Diagnostic Biomarker for Severe Pandemic Influenza A(H1N1) That Predicts Poor Clinical Outcome
por: Choreño-Parra, Jose Alberto, et al.
Publicado: (2021) -
Expression of Surfactant Protein D Distinguishes Severe Pandemic Influenza A(H1N1) from Coronavirus Disease 2019
por: Choreño-Parra, José Alberto, et al.
Publicado: (2021) -
Clinical Risk Factors for Mortality Among Critically Ill Mexican Patients With COVID-19
por: Hernández-Cárdenas, Carmen M., et al.
Publicado: (2021) -
CD4+ T Cell Regulatory Network Underlies the Decrease in Th1 and the Increase in Anergic and Th17 Subsets in Severe COVID-19
por: Martinez-Sánchez, Mariana Esther, et al.
Publicado: (2022)